Profil bibliographique

Wanassanan Madmanee

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

17Publications signalées

461Citations signalées

2Affiliations récentes

Institutions déclarées

Mahidol University Mahidol Oxford Tropical Medicine Research Unit

Domaines associés

COVID-19 Clinical Research StudiesRespiratory viral infections researchMalaria Research and ControlSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19

Publications récentes

Accès ouvert 2026 article

Molecular characterization of antimalarial resistance and hrp2/3 deletions in Plasmodium falciparum strains from Mtwara, Tanzania (2021–2024)

Piyathida Thapradit, Watcharee Pagornrat, Wanassanan Madmanee, Raweewan Sangsri et autres

0 citationsMalaria Journal

Accès ouvert 2026 article

Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial

Podjanee Jittamala, William H K Schilling, Stije J. Leopold, James A Watson et autres

0 citationsThe Lancet Infectious Diseases

Accès ouvert 2025 article

Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

William HK Schilling, Podjanee Jittamala, Phrutsamon Wongnak, James A Watson et autres

7 citationsThe Lancet Infectious Diseases

Accès ouvert 2025 article

Can malaria rapid diagnostic tests be used to detect simian malaria?

Wanassanan Madmanee, Nicholas Day, Nicholas J. White, Arjen M. Dondorp et autres

1 citationActa Tropica

Accès ouvert 2025 preprint

Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19

William HK Schilling, Podjanee Jittamala, Phrutsamon Wongnak, James A Watson et autres

0 citationsmedRxiv

Accès ouvert 2025 article

Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)

Podjanee Jittamala, Simon Boyd, William HK Schilling, James A Watson et autres

6 citationsEClinicalMedicine

Accès ouvert 2024 preprint

Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)

Podjanee Jittamala, Simon Boyd, William HK Schilling, James A Watson et autres

6 citationsmedRxiv

Accès ouvert 2024 article

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

Viravarn Luvira, William HK Schilling, Podjanee Jittamala, James A Watson et autres

31 citationsBMC Infectious Diseases

Accès ouvert 2023 article

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

William HK Schilling, Podjanee Jittamala, James A Watson, Simon Boyd et autres

97 citationsThe Lancet Infectious Diseases

Accès ouvert 2023 article

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria

Mavuto Mukaka, Marie A. Onyamboko, Peter Olupot‐Olupot, Pimnara Peerawaranun et autres

15 citationsEBioMedicine

Accès ouvert 2023 article

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)

Podjanee Jittamala, William HK Schilling, James A Watson, Viravarn Luvira et autres

29 citationsThe Journal of Infectious Diseases

Accès ouvert 2023 preprint

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open- label, randomised, controlled adaptive platform trial

Viravarn Luvira, William HK Schilling, Podjanee Jittamala, James A Watson et autres

2 citationsResearch Square

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.